Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NVAX
Novavax Inc
7.15
0.26 (3.77%)
Volume: 4,104,111
Day Range: 6.795 - 7.265
Last Trade Time: 7:59:42 PM EDT
So many bagholders with $200/share averages.
thanks for your wonderful words...
I am glad I got in here at 7.13.... however, like all of us, I should have bought more.... lol
NVAX
Novavax Inc
7.5675
-0.1025 (-1.34%)
Volume: 264,535
Day Range: 7.54 - 7.71
Bid: 7.56
Ask: 7.57
Last Trade Time: 10:05:15 AM EDT
Total Trades: 1,763
Thanks for your updates.... I'm dipping my toes in here...
BACK TO SQUARE ONE WE STARTED HERE WHEN COVID-19 HIT AMERICA
NVAX
Novavax Inc
7.67
0.11 (1.46%)
Volume: 3,450,580
Day Range: 7.33 - 7.765
Last Trade Time: 7:54:09 PM EDT
NVAX
Novavax Inc
7.67
0.11 (1.46%)
Volume: 3,450,580
Day Range: 7.33 - 7.765
Last Trade Time: 7:54:09 PM EDT
NVAX
Novavax Inc
9.16
-0.36 (-3.78%)
Volume: 3,979,041
Day Range: 9.01 - 9.535
Last Trade Time: 7:59:53 PM EDT
Still more boom to run up .
Is that still your view?
Another company will benefit tremendously from the pipeline. Who will be buying?
Welcome! They said within a Year so who knows. We could all be dead in a year lol.
Thanks, I had missed that
You didn’t read their News yesterday? They said they expect to not be able to run their business soon.
NVAX
Novavax Inc
8.82
-0.25 (-2.76%)
Volume: 3,520,793
Day Range: 8.67 - 8.91
Last Trade Time: 7:57:38 PM EST
yes hearing bad stuff
re;
BE CAREFUL - Just saw this news article. MIGHT be rough sledding tomorrow.
Sixty-one cases of myocarditis, pericarditis, or both following a Novavax vaccination were reported in the World Health Organization’s vaccine safety database through Aug. 23, 2022, Spanish researchers found.
Using pre-pandemic rates of heart inflammation in the population, the researchers calculated that the number of post-vaccination cases was higher than expected.
Reporting odds ratio values of higher than one indicate a higher-than-expected rate. For myocarditis following Novavax vaccination, the ratio was 5.2. For pericarditis, it was 24.75. For myopericarditis, or both conditions at once, it was 14.4.
Heart inflammation is a known side effect of the Pfizer and Moderna COVID-19 vaccines, which utilize messenger RNA (mRNA) technology, but little data has been collected on the condition following Novavax vaccination, which does not contain mRNA.
Novavax COVID-19 Vaccine Associated with Heart Inflammation: Study
BE CAREFUL - Just saw this news article. MIGHT be rough sledding tomorrow.
Sixty-one cases of myocarditis, pericarditis, or both following a Novavax vaccination were reported in the World Health Organization’s vaccine safety database through Aug. 23, 2022, Spanish researchers found.
Using pre-pandemic rates of heart inflammation in the population, the researchers calculated that the number of post-vaccination cases was higher than expected.
Reporting odds ratio values of higher than one indicate a higher-than-expected rate. For myocarditis following Novavax vaccination, the ratio was 5.2. For pericarditis, it was 24.75. For myopericarditis, or both conditions at once, it was 14.4.
Heart inflammation is a known side effect of the Pfizer and Moderna COVID-19 vaccines, which utilize messenger RNA (mRNA) technology, but little data has been collected on the condition following Novavax vaccination, which does not contain mRNA.
Novavax COVID-19 Vaccine Associated with Heart Inflammation: Study
NVAX
Novavax Inc
11.27
-0.74 (-6.16%)
Volume: 6,466,637
Day Range: 11.18 - 12.2799
Bid: 11.23
Ask: 11.29
Last Trade Time: 7:59:58 PM EST
Total Trades: 49,307
FDA_briefing_document_for VRBPAC advisory_committee—>bullish for PFE/MRNA/NVAX:
https://www.fda.gov/media/164699/download (p.5; p.18)
FDA anticipates conducting an assessment of SARS-CoV-2 strains at least annually and to engage VRBPAC in about early June of each year regarding strain selection for the fall season. Subsequently, a decision on the recommended vaccine composition would be made in time for any updated vaccine to be in production in time to be deployed for use no later than September of each calendar year.
…FDA expects that simplification of COVID-19 vaccine composition and annual immunization schedules may contribute to more facile vaccine deployment, fewer vaccine administration errors, and less complex communication, all potentially leading to improved vaccine coverage rates and, ultimately, to enhanced public health.
NVAX gets great news and runs almost to $13 on Monday. Last Friday's action gave a clue on news coming.
That did not take long. More fun to come as we set in under $10.
mb
NVAX getting closer to $13s.
Just waiting for the sudden breakaway in January which will alarm the shorts.
mb
yes, NVAX
Novavax Inc
11.685
0.355 (3.13%)
Volume: 4,905,686
Day Range: 10.57 - 11.805
Bid: 11.68
Ask: 11.69
Last Trade Time: 1:23:53 PM EST
Total Trades: 36,021
Mick-
NVAX will eventually be trading in the upper teens. The company now has a sudden global appeal.
Lots of cash flowing into NVAX now.
mb
RETREADED FROM OVER $75 2022 $NVAX
through 2022 $NVAX
http://www.stockta.com/cgi-bin/analysis.pl?symb=NVAX
https://www.stockscores.com/charts/charts/?ticker=NVAX
https://seekingalpha.com/symbol/NVAX
https://www.otcmarkets.com/stock/NVAX
https://stockcharts.com/h-sc/ui
https://stockcharts.com/c-sc/sc?s=NVAX&p=D&b=5&g=0&i=t0176762015c&r=1671227019029
NVAX
Novavax Inc
9.9412
-0.3388 (-3.30%)
Volume: 2,642,538
Day Range: 9.89 - 11.12
Bid: 9.94
Ask: 9.95
Last Trade Time: 10:31:12 AM EST
Total Trades: 15,930
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates 12/30/2022 08:00:00 AM
yes, dis started wit covid @ under $7 wow returning to under $10
$NVAX reloaded the sub $10 pullback when market tanked.
With increasing china virus infections.
Nvax should be able to get billion dosea aupply to china with help of Serum Institutes of india.
We will see
NVAX
Novavax Inc
11.00
-0.32 (-2.83%)
Volume: 38,702,375
Day Range: 9.36 - 11.16
Last Trade Time: 8:00:00 PM EST
Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster
Just wish there were more options (LOCATIONS!) for receiving Novavax vaccines!
As of today correct but when I posted that it looked ready to breakout
Starting to move.
The analyst’s rating stays a Buy, while his $126 price target suggests investors could be sitting on returns of 314% in a year’s time.
Can’t wait
NVAX
Novavax Inc
32.87
-2.35 (-6.67%)
Volume: 4,572,181
Day Range: 32.61 - 36.165
Bid: 32.76
Ask: 32.95
Last Trade Time: 6:45:27 PM EDT
Total Trades: 52,449
NVAX Detailed Quote
Novavax to Participate in Fireside Chat at the SVB Securities Virtual Vaccine Forum.
https://ih.advfn.com/stock-market/NASDAQ/novavax-NVAX/stock-news/88819100/novavax-to-participate-in-fireside-chat-at-the-svb
$NVAX and Serum Institute of India to develop #monkeypox vaccine: https://www.businesstoday.in/latest/trends/story/indian-pharma-cos-to-develop-monkeypox-vaccines-drugs-and-testing-kits-342813-2022-07-26
Followers
|
338
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8533
|
Created
|
06/19/03
|
Type
|
Free
|
Moderators mick JoeForkeyBolo |
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases.
Using innovative proprietary recombinant nanoparticle vaccine technology,
we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...
INVESTORS
Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease. More...
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |